JP2012526820A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012526820A5 JP2012526820A5 JP2012510917A JP2012510917A JP2012526820A5 JP 2012526820 A5 JP2012526820 A5 JP 2012526820A5 JP 2012510917 A JP2012510917 A JP 2012510917A JP 2012510917 A JP2012510917 A JP 2012510917A JP 2012526820 A5 JP2012526820 A5 JP 2012526820A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- hydrogen
- aryl
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims description 114
- 239000001257 hydrogen Substances 0.000 claims description 114
- 150000001875 compounds Chemical class 0.000 claims description 104
- 125000000217 alkyl group Chemical group 0.000 claims description 102
- -1 carbamoyloxy Chemical group 0.000 claims description 102
- 125000003118 aryl group Chemical group 0.000 claims description 85
- 150000002431 hydrogen Chemical class 0.000 claims description 78
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims description 65
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 64
- 125000001072 heteroaryl group Chemical group 0.000 claims description 64
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 63
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 63
- 229910052801 chlorine Inorganic materials 0.000 claims description 62
- 229910052794 bromium Inorganic materials 0.000 claims description 60
- 125000005144 cycloalkylsulfonyl group Chemical group 0.000 claims description 60
- 229910052731 fluorine Inorganic materials 0.000 claims description 60
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 claims description 59
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 59
- 125000005226 heteroaryloxycarbonyl group Chemical group 0.000 claims description 59
- 229910004013 NO 2 Inorganic materials 0.000 claims description 58
- 150000001408 amides Chemical class 0.000 claims description 58
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 57
- 125000004423 acyloxy group Chemical group 0.000 claims description 48
- 125000005333 aroyloxy group Chemical group 0.000 claims description 46
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 claims description 45
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 45
- 125000003545 alkoxy group Chemical group 0.000 claims description 43
- 125000004414 alkyl thio group Chemical group 0.000 claims description 43
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 40
- 125000006350 alkyl thio alkyl group Chemical group 0.000 claims description 39
- 125000000000 cycloalkoxy group Chemical group 0.000 claims description 39
- 125000005367 heteroarylalkylthio group Chemical group 0.000 claims description 39
- 125000005553 heteroaryloxy group Chemical group 0.000 claims description 38
- 125000005368 heteroarylthio group Chemical group 0.000 claims description 38
- 125000005110 aryl thio group Chemical group 0.000 claims description 37
- 125000004659 aryl alkyl thio group Chemical group 0.000 claims description 36
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims description 36
- 125000004104 aryloxy group Chemical group 0.000 claims description 36
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 claims description 33
- 125000004366 heterocycloalkenyl group Chemical group 0.000 claims description 28
- 125000002252 acyl group Chemical group 0.000 claims description 27
- 125000004688 alkyl sulfonyl alkyl group Chemical group 0.000 claims description 27
- 150000003839 salts Chemical class 0.000 claims description 13
- 125000001188 haloalkyl group Chemical group 0.000 claims description 11
- 125000003282 alkyl amino group Chemical group 0.000 claims description 10
- 229910052757 nitrogen Inorganic materials 0.000 claims description 10
- 239000008194 pharmaceutical composition Substances 0.000 claims description 9
- 241000700605 Viruses Species 0.000 claims description 8
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 8
- 125000001153 fluoro group Chemical group F* 0.000 claims description 8
- 229910052760 oxygen Inorganic materials 0.000 claims description 8
- 229910052717 sulfur Inorganic materials 0.000 claims description 8
- 208000036142 Viral infection Diseases 0.000 claims description 7
- 150000002148 esters Chemical class 0.000 claims description 7
- 125000005114 heteroarylalkoxy group Chemical group 0.000 claims description 7
- 125000005241 heteroarylamino group Chemical group 0.000 claims description 7
- 125000005842 heteroatom Chemical group 0.000 claims description 7
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 7
- 230000009385 viral infection Effects 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 5
- 125000004422 alkyl sulphonamide group Chemical group 0.000 claims description 5
- 230000000840 anti-viral effect Effects 0.000 claims description 5
- 125000004429 atom Chemical group 0.000 claims description 5
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 5
- 125000005112 cycloalkylalkoxy group Chemical group 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 5
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims description 4
- 241000709661 Enterovirus Species 0.000 claims description 4
- 241000700588 Human alphaherpesvirus 1 Species 0.000 claims description 4
- 241000701074 Human alphaherpesvirus 2 Species 0.000 claims description 4
- 241000701024 Human betaherpesvirus 5 Species 0.000 claims description 4
- 241000701044 Human gammaherpesvirus 4 Species 0.000 claims description 4
- 241000725643 Respiratory syncytial virus Species 0.000 claims description 4
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 claims description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 claims description 3
- 230000002496 gastric effect Effects 0.000 claims description 3
- 230000000241 respiratory effect Effects 0.000 claims description 3
- 241001529453 unidentified herpesvirus Species 0.000 claims description 3
- 229940080296 2-naphthalenesulfonate Drugs 0.000 claims description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical group CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- 201000006082 Chickenpox Diseases 0.000 claims description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 2
- 241000711573 Coronaviridae Species 0.000 claims description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 102000014150 Interferons Human genes 0.000 claims description 2
- 108010050904 Interferons Proteins 0.000 claims description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 2
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 claims description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 2
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 2
- 208000002606 Paramyxoviridae Infections Diseases 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 241000702670 Rotavirus Species 0.000 claims description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 claims description 2
- 206010046980 Varicella Diseases 0.000 claims description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 claims description 2
- 229940072056 alginate Drugs 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 claims description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 2
- 229910052782 aluminium Inorganic materials 0.000 claims description 2
- 229940009098 aspartate Drugs 0.000 claims description 2
- ZXVOCOLRQJZVBW-UHFFFAOYSA-N azane;ethanol Chemical compound N.CCO ZXVOCOLRQJZVBW-UHFFFAOYSA-N 0.000 claims description 2
- 229940077388 benzenesulfonate Drugs 0.000 claims description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 claims description 2
- 229940050390 benzoate Drugs 0.000 claims description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 claims description 2
- 229940043264 dodecyl sulfate Drugs 0.000 claims description 2
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 claims description 2
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 claims description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 claims description 2
- 208000037797 influenza A Diseases 0.000 claims description 2
- 208000037798 influenza B Diseases 0.000 claims description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 claims description 2
- 229910052744 lithium Inorganic materials 0.000 claims description 2
- 229940049920 malate Drugs 0.000 claims description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 2
- KVBGVZZKJNLNJU-UHFFFAOYSA-M naphthalene-2-sulfonate Chemical compound C1=CC=CC2=CC(S(=O)(=O)[O-])=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-M 0.000 claims description 2
- 235000001968 nicotinic acid Nutrition 0.000 claims description 2
- 239000011664 nicotinic acid Substances 0.000 claims description 2
- 239000002777 nucleoside Substances 0.000 claims description 2
- 150000003833 nucleoside derivatives Chemical class 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- CBXCPBUEXACCNR-UHFFFAOYSA-N tetraethylammonium Chemical compound CC[N+](CC)(CC)CC CBXCPBUEXACCNR-UHFFFAOYSA-N 0.000 claims description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 claims description 2
- 241000701161 unidentified adenovirus Species 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 12
- 125000001151 peptidyl group Chemical group 0.000 claims 2
- 125000004963 sulfonylalkyl group Chemical group 0.000 claims 2
- LSPHULWDVZXLIL-UHFFFAOYSA-N (+/-)-Camphoric acid Chemical compound CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 claims 1
- 229940047124 interferons Drugs 0.000 claims 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 63
- 125000001691 aryl alkyl amino group Chemical group 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 125000003302 alkenyloxy group Chemical group 0.000 description 4
- 125000000304 alkynyl group Chemical group 0.000 description 4
- 125000005133 alkynyloxy group Chemical group 0.000 description 4
- 125000001769 aryl amino group Chemical group 0.000 description 4
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 4
- 125000004438 haloalkoxy group Chemical group 0.000 description 4
- 125000005143 heteroarylsulfonyl group Chemical group 0.000 description 4
- 125000005137 alkenylsulfonyl group Chemical group 0.000 description 3
- 125000005139 alkynylsulfonyl group Chemical group 0.000 description 3
- 125000005140 aralkylsulfonyl group Chemical group 0.000 description 3
- 125000004663 dialkyl amino group Chemical group 0.000 description 3
- 125000004447 heteroarylalkenyl group Chemical group 0.000 description 3
- 244000052613 viral pathogen Species 0.000 description 3
- 125000005452 alkenyloxyalkyl group Chemical group 0.000 description 2
- 125000000278 alkyl amino alkyl group Chemical group 0.000 description 2
- 125000005018 aryl alkenyl group Chemical group 0.000 description 2
- 125000005015 aryl alkynyl group Chemical group 0.000 description 2
- 125000004465 cycloalkenyloxy group Chemical group 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000005312 heteroarylalkynyl group Chemical group 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- ZRPLANDPDWYOMZ-UHFFFAOYSA-N 3-cyclopentylpropionic acid Chemical compound OC(=O)CCC1CCCC1 ZRPLANDPDWYOMZ-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241000711549 Hepacivirus C Species 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 241000243251 Hydra Species 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-O Methylammonium ion Chemical compound [NH3+]C BAVYZALUXZFZLV-UHFFFAOYSA-O 0.000 description 1
- 241001024304 Mino Species 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 125000005035 acylthio group Chemical group 0.000 description 1
- 125000006323 alkenyl amino group Chemical group 0.000 description 1
- 125000005108 alkenylthio group Chemical group 0.000 description 1
- 125000005082 alkoxyalkenyl group Chemical group 0.000 description 1
- 125000005910 alkyl carbonate group Chemical group 0.000 description 1
- 125000005599 alkyl carboxylate group Chemical group 0.000 description 1
- 125000006319 alkynyl amino group Chemical group 0.000 description 1
- 125000005109 alkynylthio group Chemical group 0.000 description 1
- 125000006326 aryl hydrazinyl group Chemical group 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 125000006310 cycloalkyl amino group Chemical group 0.000 description 1
- 125000005356 cycloalkylalkenyl group Chemical group 0.000 description 1
- 125000005357 cycloalkylalkynyl group Chemical group 0.000 description 1
- 125000005366 cycloalkylthio group Chemical group 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 125000000262 haloalkenyl group Chemical group 0.000 description 1
- 125000004995 haloalkylthio group Chemical group 0.000 description 1
- 125000000232 haloalkynyl group Chemical group 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 208000010710 hepatitis C virus infection Diseases 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- GASFVSRUEBGMDI-UHFFFAOYSA-N n-aminohydroxylamine Chemical compound NNO GASFVSRUEBGMDI-UHFFFAOYSA-N 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- 125000005004 perfluoroethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17762609P | 2009-05-12 | 2009-05-12 | |
| US61/177,626 | 2009-05-12 | ||
| PCT/US2010/034319 WO2010132404A1 (en) | 2009-05-12 | 2010-05-11 | Haloalkyl heteroaryl benzamide compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015134747A Division JP6193922B2 (ja) | 2009-05-12 | 2015-07-03 | ハロアルキルヘテロアリールベンズアミド化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012526820A JP2012526820A (ja) | 2012-11-01 |
| JP2012526820A5 true JP2012526820A5 (OSRAM) | 2013-06-27 |
| JP5918124B2 JP5918124B2 (ja) | 2016-05-18 |
Family
ID=43069021
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012510917A Active JP5918124B2 (ja) | 2009-05-12 | 2010-05-11 | ハロアルキルヘテロアリールベンズアミド化合物 |
| JP2015134747A Expired - Fee Related JP6193922B2 (ja) | 2009-05-12 | 2015-07-03 | ハロアルキルヘテロアリールベンズアミド化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015134747A Expired - Fee Related JP6193922B2 (ja) | 2009-05-12 | 2015-07-03 | ハロアルキルヘテロアリールベンズアミド化合物 |
Country Status (24)
| Country | Link |
|---|---|
| US (4) | US8846727B2 (OSRAM) |
| EP (2) | EP3078377A3 (OSRAM) |
| JP (2) | JP5918124B2 (OSRAM) |
| KR (1) | KR101760956B1 (OSRAM) |
| CN (2) | CN102803203B (OSRAM) |
| AP (1) | AP3074A (OSRAM) |
| AU (2) | AU2010247816B2 (OSRAM) |
| BR (1) | BRPI1010547A2 (OSRAM) |
| CA (2) | CA2940954A1 (OSRAM) |
| CL (1) | CL2011002830A1 (OSRAM) |
| CO (1) | CO6460766A2 (OSRAM) |
| CR (1) | CR20110607A (OSRAM) |
| DO (1) | DOP2011000353A (OSRAM) |
| EA (1) | EA021587B1 (OSRAM) |
| EC (1) | ECSP11011511A (OSRAM) |
| HK (1) | HK1223819A1 (OSRAM) |
| HN (1) | HN2011003002A (OSRAM) |
| IL (2) | IL216331B (OSRAM) |
| MX (1) | MX337460B (OSRAM) |
| NI (1) | NI201100199A (OSRAM) |
| NZ (1) | NZ596538A (OSRAM) |
| PE (1) | PE20121118A1 (OSRAM) |
| SG (2) | SG176045A1 (OSRAM) |
| WO (1) | WO2010132404A1 (OSRAM) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2839425B2 (ja) | 1993-04-14 | 1998-12-16 | 新日本製鐵株式会社 | ドッグボーン型粗形鋼片の製造方法 |
| KR101760956B1 (ko) | 2009-05-12 | 2017-07-24 | 로마크 레버러토리즈, 엘.씨. | 할로알킬 헤테로아릴 벤즈아미드 화합물 |
| KR20180032689A (ko) | 2009-06-26 | 2018-03-30 | 로마크 레버러토리즈, 엘.씨. | 인플루엔자를 치료하기 위한 화합물 및 방법 |
| DK2688885T3 (en) * | 2011-03-22 | 2016-09-12 | Bayer Ip Gmbh | N- (1,3,4-oxadiazol-2-yl) ARYLCARBOXYLSYREAMIDER AND THEIR USE AS HERBICIDES |
| WO2013017559A1 (de) * | 2011-08-03 | 2013-02-07 | Bayer Intellectual Property Gmbh | N-(tetrazol-5-yl)- und n-(triazol-5-yl)arylcarbonsäureamide und ihre verwendung als herbizide |
| US9056867B2 (en) | 2011-09-16 | 2015-06-16 | Novartis Ag | N-substituted heterocyclyl carboxamides |
| EP2928887B1 (de) | 2012-12-06 | 2016-11-16 | Bayer CropScience AG | N-(oxazol-2-yl)-arylcarbonsäureamide und ihre verwendung als herbizide |
| SG10201803698UA (en) * | 2012-12-27 | 2018-06-28 | Univ Drexel | Novel antiviral agents against hbv infection |
| JP6371077B2 (ja) * | 2014-02-25 | 2018-08-08 | 国立大学法人佐賀大学 | ジフルオロメチル基含有化合物及びその用途 |
| EP3140298A1 (en) | 2014-05-07 | 2017-03-15 | Pfizer Inc. | Tropomyosin-related kinase inhibitors |
| KR20170081228A (ko) * | 2014-11-11 | 2017-07-11 | 로마크 레버러토리즈, 엘.씨. | 티족사나이드, 그의 유사체 또는 염의 전구 약물을 이용한 치료 조성물 및 방법 |
| JP6818690B2 (ja) | 2014-12-01 | 2021-01-20 | シンジェンタ パーティシペーションズ アーゲー | 硫黄含有置換基を有する殺有害生物的に活性なアミド複素環式誘導体 |
| MX384836B (es) | 2016-03-07 | 2025-03-14 | Enanta Pharm Inc | Agentes antivirales contra la hepatitis b |
| HUE050601T2 (hu) | 2016-03-31 | 2020-12-28 | Romark Laboratories Lc | Tiazolidvegyületek vírusfertõzések kezelésére |
| PH12018502142B1 (en) | 2016-04-11 | 2023-08-11 | Genfit | Methods of treatment for cholestatic and fibrotic diseases |
| EP3558986A1 (de) | 2016-12-22 | 2019-10-30 | Bayer CropScience Aktiengesellschaft | Substituierte 1,2,4-thiadiazolylpyrrolone und 1,2,4-thiadiazolylhydantoine sowie deren salze und ihre verwendung als herbizide wirkstoffe |
| US11173149B2 (en) | 2017-04-18 | 2021-11-16 | Romark Laboratories L.C. | Inhibition of protein disulfide-isomerase A3 |
| EA202090514A1 (ru) | 2017-08-28 | 2020-06-24 | Энанта Фармасьютикалс, Инк. | Противовирусное средство против гепатита в |
| AU2019364352A1 (en) | 2018-10-22 | 2021-06-03 | Assembly Biosciences, Inc. | 5-membered heteroaryl carboxamide compounds for treatment of HBV |
| SG11202105007TA (en) | 2018-11-21 | 2021-06-29 | Enanta Pharm Inc | Functionalized heterocycles as antiviral agents |
| KR102873079B1 (ko) * | 2019-07-19 | 2025-10-20 | 아비박스 | Rna 바이러스 감염 치료를 위한 아릴-n-아릴 유도체 |
| WO2021016543A1 (en) * | 2019-07-25 | 2021-01-28 | Romark Laboratories L.C. | Antiviral combinations of thiazolide compounds |
| AU2020360000B2 (en) * | 2019-10-02 | 2023-04-20 | Kainos Medicine, Inc. | N-(1H-imidazol-2-yl)benzamide compound and pharmaceutical composition comprising the same as active ingredient |
| CN111187215B (zh) * | 2020-01-21 | 2023-02-24 | 西北农林科技大学 | 含氟吡唑酰胺类衍生物、制备方法及其应用 |
| JP2023512622A (ja) * | 2020-01-21 | 2023-03-28 | アカデミー オブ ミリタリー メディカル サイエンシズ | ニタゾキサニド及びその活性型であるチゾキサニドのＳＡＲＳ－ＣｏＶ－２感染症の治療への適用 |
| US20230241037A1 (en) * | 2020-03-09 | 2023-08-03 | 1Globe Health Institute, Nanjing | Cross-linked medication for treatment of coronaviral infection and method of treatment |
| US11802125B2 (en) | 2020-03-16 | 2023-10-31 | Enanta Pharmaceuticals, Inc. | Functionalized heterocyclic compounds as antiviral agents |
| CN113398125B (zh) | 2020-03-16 | 2024-05-03 | 绍兴君科臻元医药科技有限公司 | 替唑尼特药物组合物及其医药用途 |
| EP4182304A1 (en) | 2020-07-20 | 2023-05-24 | Romark Laboratories, L.C. | Crystalline salts of tizoxanide and 2-hydroxy-n-(5-chloro-1,3-thiazol-2-yl)benzamide (rm-4848) with ethanolamine, morpholine, propanolamine, piperazine and n-methylpiperazine |
| CN116367892A (zh) | 2020-08-24 | 2023-06-30 | 罗马克实验室有限公司 | 噻唑化物抗冠状病毒的用途 |
| KR20230084530A (ko) * | 2020-10-09 | 2023-06-13 | 브리스톨-마이어스 스큅 컴퍼니 | 아미노이미다졸 fpr2 효능제 |
| WO2022109148A1 (en) * | 2020-11-18 | 2022-05-27 | The Usa, As Represented By The Secretary, Dept. Of Health And Human Services | Small molecule inhibitors of sars-cov-2 infections |
| WO2022130406A1 (en) * | 2020-12-15 | 2022-06-23 | Cipla Limited | Inhalation composition of nitazoxanide or its derivatives for use in coronavirus disease |
| US12146029B1 (en) | 2021-02-08 | 2024-11-19 | Futurefuel Chemical Company | Polymers enhanced with hydrated sodium sulfoisophthalic acid salts |
| CN116003323B (zh) * | 2023-02-14 | 2023-12-08 | 西北农林科技大学 | 含氟吡唑苯乙酰胺类衍生物及其应用 |
Family Cites Families (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1177206A (en) | 1967-11-28 | 1970-01-07 | Pfizer & Co C | Lung Antiviral Factor |
| GB1437800A (en) | 1973-08-08 | 1976-06-03 | Phavic Sprl | Derivatives of 2-benzamido-5-nitro-thiazoles |
| US4343945A (en) * | 1979-01-23 | 1982-08-10 | Olin Corporation | 5-Benzamido-3-trichloromethyl-1,2,4-thiadiazoles and their use as herbicides, fungicides and insecticides |
| US4337081A (en) * | 1979-01-23 | 1982-06-29 | Olin Corporation | 5-Amido-3-trihalomethyl-1,2,4-thiadiazoles and their use as herbicides |
| SU910628A1 (ru) | 1980-04-22 | 1982-03-07 | Гродненский государственный медицинский институт | Способ получени 2-ациламинотиазолов |
| JPS56158703A (en) | 1980-05-10 | 1981-12-07 | Sankyo Co Ltd | Fungicide |
| US4416683A (en) | 1980-09-16 | 1983-11-22 | Eli Lilly And Company | Benzamides, compositions and agricultural method |
| MA19269A1 (fr) * | 1980-09-16 | 1982-04-01 | Lilly Co Eli | Perfectionnement relatif a des derives de n-arylbenzamides . |
| JPS649978A (en) * | 1987-07-02 | 1989-01-13 | Shionogi & Co | Perfluoroalkylisoxazole derivative |
| US4874864A (en) | 1988-05-24 | 1989-10-17 | Pfizer Inc. | Benzamide protease inhibitors |
| US5169846A (en) | 1989-10-12 | 1992-12-08 | Crooks Michael J | Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators |
| WO1995020567A1 (en) | 1994-01-28 | 1995-08-03 | University Of Kentucky Research Foundation | Codrugs as a method of controlled drug delivery |
| CN1072654C (zh) * | 1994-04-13 | 2001-10-10 | 让-弗兰克伊斯·罗西格诺尔 | 苯甲酰胺衍生物,含所述衍生物的组合物及它们的用途 |
| US5578621A (en) | 1994-09-08 | 1996-11-26 | Romark Lab Lc | Benzamide derivatives |
| US5968961A (en) | 1997-05-07 | 1999-10-19 | Romark Laboratories, L.C. | Pharmaceutical compositions of tizoxanide and nitazoxanide |
| MX9604483A (es) | 1994-09-08 | 1998-02-28 | Jean-Francois Rossignol | Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas. |
| TR199902733T2 (xx) * | 1997-05-07 | 2000-03-21 | Romark Laboratories, L.C. | Tizoksanit ve nitazoksanitten olu�an farmas�tik kompozisyonlar. |
| GB9725298D0 (en) * | 1997-11-28 | 1998-01-28 | Zeneca Ltd | Insecticidal thiazole derivatives |
| HU228111B1 (en) | 1998-07-08 | 2012-11-28 | Sanofi Aventis Deutschland | Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| GB9823871D0 (en) | 1998-10-30 | 1998-12-23 | Pharmacia & Upjohn Spa | 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents |
| US6849254B1 (en) | 1999-04-19 | 2005-02-01 | Schering Corporation | HCV combination therapy |
| US6136835A (en) | 1999-05-17 | 2000-10-24 | The Procter & Gamble Company | Methods of treatment for viral infections |
| DK1347971T3 (da) * | 2000-12-21 | 2006-05-15 | Bristol Myers Squibb Co | Thiazolylinhibitorer af tyrosinkinaser fra Tec-familien |
| DE60208630T2 (de) * | 2001-05-11 | 2006-08-17 | Pfizer Products Inc., Groton | Thiazolderivate und ihre Verwendung als cdk-Inhibitoren |
| WO2002092584A1 (en) * | 2001-05-14 | 2002-11-21 | Nihon Nohyaku Co., Ltd. | Thiadiazole derivatives, pesticides for agricultural and horticultural use and usage thereof |
| SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| JP2003335680A (ja) | 2002-05-21 | 2003-11-25 | Otsuka Pharmaceut Factory Inc | Ａｃａｔ−１阻害剤 |
| EP1510207A4 (en) * | 2002-06-05 | 2008-12-31 | Inst Med Molecular Design Inc | THERAPEUTIC MEDICAMENT AGAINST DIABETES |
| AU2003279010A1 (en) | 2002-09-28 | 2004-04-19 | Massachusetts Institute Of Technology | Compositions and methods for delivery of short interfering rna and short hairpin rna |
| US20040242518A1 (en) | 2002-09-28 | 2004-12-02 | Massachusetts Institute Of Technology | Influenza therapeutic |
| US6737382B1 (en) | 2002-10-23 | 2004-05-18 | Nippon Soda Co. Ltd. | Insecticidal aminothiazole derivatives |
| US7807174B2 (en) | 2002-11-22 | 2010-10-05 | Nexbio, Inc. | Class of therapeutic protein based molecules |
| MXPA05009059A (es) | 2003-02-26 | 2005-10-19 | Banyu Pharma Co Ltd | Derivados de heteroarilcarbamoilbenceno. |
| US7285576B2 (en) | 2003-03-12 | 2007-10-23 | 3M Innovative Properties Co. | Absorbent polymer compositions, medical articles, and methods |
| JP2006521345A (ja) * | 2003-03-28 | 2006-09-21 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | ニコチン性アセチルコリン受容体の正のアロステリック調節剤 |
| RU2006104697A (ru) * | 2003-07-16 | 2006-06-27 | Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. (Jp) | Лекарственное средство для лечения пигментации кожи |
| US20050090506A1 (en) | 2003-10-24 | 2005-04-28 | Nippon Soda Co., Ltd. | Insecticidal perfluoroalkylthiazole derivatives |
| US7683097B2 (en) * | 2004-05-27 | 2010-03-23 | Propharmacon Inc. | Topoisomerase inhibitors |
| UA90864C2 (en) * | 2004-09-09 | 2010-06-10 | Ромарк Лебораториз, Л.К. | Halogenated benzamide derivatives |
| US20060194853A1 (en) | 2004-10-08 | 2006-08-31 | Rossignol Jean F | Alkyl benzamides |
| US8357664B2 (en) | 2004-10-26 | 2013-01-22 | Avi Biopharma, Inc. | Antisense antiviral compound and method for treating influenza viral infection |
| WO2006110814A2 (en) * | 2005-04-12 | 2006-10-19 | Romark Laboratories, L.C. | Methods for treating diseases through inhibition the function of molecular chaperones such as protein disulfide isomerases, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents |
| BRPI0608910A2 (pt) | 2005-05-09 | 2010-02-17 | Achillion Pharmaceuticals Inc | uso de um composto da fórmula ou um sal ou hidrato farmaceuticamente aceitável desse, composto ou sal ou hidrato do mesmo, composição farmacêutica e composição farmacêutica embalada |
| EP2029138A1 (en) | 2005-06-03 | 2009-03-04 | Xenon Pharmaceuticals Inc. | Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| TW200711649A (en) | 2005-06-17 | 2007-04-01 | Combinatorx Inc | Combination therapy for the treatment of immunoinflammatory disorders |
| EP1910307A1 (en) | 2005-06-27 | 2008-04-16 | Exelixis, Inc. | Pyrazole based lxr modulators |
| WO2007008541A2 (en) | 2005-07-08 | 2007-01-18 | Kalypsys, Inc. | Cellular cholesterol absorption modifiers |
| AU2006275849A1 (en) | 2005-08-02 | 2007-02-08 | Irm Llc | 5-substituted thiazol-2-yl amino compounds and compositions as protein kinase inhibitors |
| ES2378473T3 (es) * | 2005-12-21 | 2012-04-12 | Abbott Laboratories | Compuestos antivirales |
| CN101448497B (zh) * | 2006-01-09 | 2013-07-10 | 罗马克实验室有限公司 | 包含硝唑尼特、替唑尼特、或其混合物的组合物在制备治疗丙型肝炎药物中的应用 |
| CA2649577A1 (en) | 2006-04-28 | 2007-11-08 | Transtech Pharma, Inc. | Benzamide glucokinase activators |
| AU2007266535A1 (en) * | 2006-05-31 | 2007-12-06 | Abbott Laboratories | Thiazole compounds as cannabinoid receptor ligands and uses thereof |
| MX2008015457A (es) * | 2006-07-07 | 2009-01-16 | Boehringer Ingelheim Int | Derivados de heteroaril substituido en fenil y el uso de los mismos como agentes anti-tumorales. |
| WO2008033466A2 (en) | 2006-09-14 | 2008-03-20 | Combinatorx (Singapore) Pre. Ltd. | Compositions and methods for treatment of viral diseases |
| JP2010511728A (ja) * | 2006-12-05 | 2010-04-15 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | Ｉｌ−８受容体アンタゴニスト |
| WO2009001214A2 (en) * | 2007-06-28 | 2008-12-31 | Pfizer Products Inc. | Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrimidin-4(5h)-one derivatives as calcium receptor antagonists |
| AU2008299781B2 (en) * | 2007-08-03 | 2013-11-14 | Romark Laboratories L.C. | Alkylsulfonyl-substituted thiazolide compounds |
| US8486987B2 (en) * | 2007-11-16 | 2013-07-16 | University Of Medicine And Dentistry Of New Jersey | Mechanism-based small-molecule parasite inhibitors |
| US20100081713A1 (en) | 2008-03-19 | 2010-04-01 | CombinatoRx, (Singapore) Pte. Ltd. | Compositions and methods for treating viral infections |
| US20100009970A1 (en) | 2008-03-19 | 2010-01-14 | Combinatorx (Singapore) Pte. Ltd. | Compositions and methods for treatment of viral diseases |
| CN102089278A (zh) * | 2008-06-11 | 2011-06-08 | Irm责任有限公司 | 用于治疗疟疾的化合物和组合物 |
| AR073501A1 (es) * | 2008-09-08 | 2010-11-10 | Boehringer Ingelheim Int | Derivados de pirimido[5,4-d]pirimidina inhibidores de la tirosinoquinasa |
| UY32138A (es) * | 2008-09-25 | 2010-04-30 | Boehringer Ingelheim Int | Amidas sustituidas del ácido 2-(2,6-dicloro-fenilamino)-6-fluoro-1-metil-1h-bencimidazol-5-carboxílico y sus sales farmacéuticamente aceptables |
| US20110224136A1 (en) * | 2008-11-19 | 2011-09-15 | Ting Pauline C | Inhibitors of diacylglycerol acyltransferase |
| US8835644B2 (en) | 2009-03-20 | 2014-09-16 | University Of Virginia Patent Foundation | Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials |
| KR101760956B1 (ko) | 2009-05-12 | 2017-07-24 | 로마크 레버러토리즈, 엘.씨. | 할로알킬 헤테로아릴 벤즈아미드 화합물 |
| KR20180032689A (ko) | 2009-06-26 | 2018-03-30 | 로마크 레버러토리즈, 엘.씨. | 인플루엔자를 치료하기 위한 화합물 및 방법 |
-
2010
- 2010-05-11 KR KR1020117029247A patent/KR101760956B1/ko not_active Expired - Fee Related
- 2010-05-11 CN CN201080031243.1A patent/CN102803203B/zh not_active Expired - Fee Related
- 2010-05-11 AU AU2010247816A patent/AU2010247816B2/en not_active Ceased
- 2010-05-11 NZ NZ596538A patent/NZ596538A/en not_active IP Right Cessation
- 2010-05-11 SG SG2011083573A patent/SG176045A1/en unknown
- 2010-05-11 CA CA2940954A patent/CA2940954A1/en not_active Abandoned
- 2010-05-11 US US12/777,383 patent/US8846727B2/en active Active
- 2010-05-11 JP JP2012510917A patent/JP5918124B2/ja active Active
- 2010-05-11 EP EP16167043.5A patent/EP3078377A3/en not_active Withdrawn
- 2010-05-11 BR BRPI1010547-6A patent/BRPI1010547A2/pt not_active Application Discontinuation
- 2010-05-11 EP EP10775367.5A patent/EP2429986B1/en not_active Not-in-force
- 2010-05-11 AP AP2011006015A patent/AP3074A/xx active
- 2010-05-11 EA EA201171378A patent/EA021587B1/ru not_active IP Right Cessation
- 2010-05-11 CN CN201610225952.2A patent/CN105853415A/zh active Pending
- 2010-05-11 CA CA2761876A patent/CA2761876C/en not_active Expired - Fee Related
- 2010-05-11 SG SG10201402281WA patent/SG10201402281WA/en unknown
- 2010-05-11 MX MX2011012040A patent/MX337460B/es active IP Right Grant
- 2010-05-11 WO PCT/US2010/034319 patent/WO2010132404A1/en not_active Ceased
- 2010-05-11 PE PE2011001963A patent/PE20121118A1/es not_active Application Discontinuation
-
2011
- 2011-11-11 HN HN2011003002A patent/HN2011003002A/es unknown
- 2011-11-11 CL CL2011002830A patent/CL2011002830A1/es unknown
- 2011-11-11 NI NI201100199A patent/NI201100199A/es unknown
- 2011-11-13 IL IL216331A patent/IL216331B/en active IP Right Grant
- 2011-11-14 DO DO2011000353A patent/DOP2011000353A/es unknown
- 2011-11-15 CO CO11154944A patent/CO6460766A2/es not_active Application Discontinuation
- 2011-11-18 CR CR20110607A patent/CR20110607A/es unknown
- 2011-12-09 EC ECSP11011511 patent/ECSP11011511A/es unknown
-
2014
- 2014-08-05 US US14/451,637 patent/US9126992B2/en not_active Ceased
-
2015
- 2015-07-03 JP JP2015134747A patent/JP6193922B2/ja not_active Expired - Fee Related
- 2015-07-27 IL IL240167A patent/IL240167A0/en unknown
-
2016
- 2016-04-18 AU AU2016202439A patent/AU2016202439B2/en not_active Ceased
- 2016-05-17 US US15/156,580 patent/USRE46724E1/en active Active
- 2016-09-22 HK HK16111122.0A patent/HK1223819A1/zh unknown
-
2018
- 2018-01-08 US US15/864,411 patent/USRE47786E1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012526820A5 (OSRAM) | ||
| JP2009535307A5 (OSRAM) | ||
| JP2004527515A5 (OSRAM) | ||
| RU2006112593A (ru) | Производные 2, 4-ди(гетеро)ариламинопиримидина в качестве ингибиторов zap-70 и/или syk | |
| JP2010526145A5 (OSRAM) | ||
| JP2013516395A5 (OSRAM) | ||
| JP2008509166A5 (OSRAM) | ||
| RU2007137987A (ru) | Цис-2, 4, 5-триарилимидазолины и их применение в качестве противораковых лекарственных средств | |
| JP2016500107A5 (ja) | グルタミナーゼ阻害剤およびその使用方法 | |
| JP2006501181A5 (OSRAM) | ||
| RU2502730C2 (ru) | Сульфонамидные соединения и их применение | |
| CA2683059A1 (en) | Atropisomer of pyrrole derivative | |
| JP2017526675A5 (OSRAM) | ||
| JP2010536829A5 (OSRAM) | ||
| RU2002123350A (ru) | Дипептиднитрильные ингибиторы катепсина К | |
| RU2000112020A (ru) | Соединения пиперазина, ингибитор продуцирования tnf-альфа и /или промотор продуцирования il-10 и средство для профилактики лечения болезней на его основе | |
| RU2010136050A (ru) | 2-аминохинолиновые производные для использования в качестве ингибиторов секретазы (васе) | |
| RU2394028C2 (ru) | Производные бензилтриазолона в качестве ненуклеозидных ингибиторов обратной транскриптазы | |
| CA2392570A1 (en) | 4-pyrimidinyl-n-acyl-l-phenylalanines | |
| RU2007101236A (ru) | Новые гидантоиновые производные для лечения обструктивных заболеваний дыхательных путей | |
| RU95117068A (ru) | Антигипертриглицеридемическая композиция, способ ее получения, способ лечения или профилактики гипертриглицеридемии, применение соединений | |
| JP2015519322A5 (OSRAM) | ||
| JP2004525183A5 (OSRAM) | ||
| RU2007101237A (ru) | Гетороциклические конденсированные соединения, полезные в качестве антидиуретических агентов | |
| RU2008151755A (ru) | Ингибитор hsp90 |